CoChat

Making it or breaking it: DNA methylation and genome integrity

Sriraman, Anusha, Debnath, Turja K., Xhemalce, Blerta, Miller, Kyle M. · 2020 · Essays in Biochemistry
Cited by 65

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Cells encounter a multitude of external and internal stress-causing agents that can ultimately lead to DNA damage, mutations and disease. A cascade of signaling events counters these challenges to DNA, which is termed as the DNA damage response (DDR). The DDR preserves genome integrity by engaging appropriate repair pathways, while also coordinating cell cycle and/or apoptotic responses. Although many of the protein components in the DDR are identified, how chemical modifications to DNA impact the DDR is poorly understood. This review focuses on our current understanding of DNA methylation in maintaining genome integrity in mammalian cells. DNA methylation is a reversible epigenetic mark, which has been implicated in DNA damage signaling, repair and replication. Sites of DNA methylation can trigger mutations, which are drivers of human diseases including cancer. Indeed, alterations in DNA methylation are associated with increased susceptibility to tumorigenesis but whether this occurs through effects on the DDR, transcriptional responses or both is not entirely clear. Here, we also highlight epigenetic drugs currently in use as therapeutics that target DNA methylation pathways and discuss their effects in the context of the DDR. Finally, we pose unanswered questions regarding the interplay between DNA methylation, transcription and the DDR, positing the potential coordinated efforts of these pathways in genome integrity. While the impact of DNA methylation on gene regulation is widely understood, how this modification contributes to genome instability and mutations, either directly or indirectly, and the potential therapeutic opportunities in targeting DNA methylation pathways in cancer remain active areas of investigation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/ebc20200009

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 103

  1. Jackson, 2009, The DNA-damage response in human biology and disease, Nature, 461, 1071, 10.1038/nature08467 · DOI · Paper page
  2. Puget, 2019, Non-canonical DNA/RNA structures during transcription-coupled double-strand break repair: roadblocks or bona fide repair intermediates?, DNA Repair (Amst.), 81, 102661, 10.1016/j.dnarep.2019.102661 · DOI · Paper page
  3. Kim, 2019, Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity, Genes Dev., 33, 1751, 10.1101/gad.331231.119 · DOI
  4. Jeggo, 2016, DNA repair, genome stability and cancer: a historical perspective, Nat. Rev. Cancer, 16, 35, 10.1038/nrc.2015.4 · DOI · Paper page
  5. Goto, 1998, Regulation of X-chromosome inactivation in development in mice and humans, Microbiol. Mol. Biol. Rev., 62, 362, 10.1128/MMBR.62.2.362-378.1998 · DOI · Paper page
  6. Hermann, 2004, The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites, J. Biol. Chem., 279, 48350, 10.1074/jbc.M403427200 · DOI · Paper page
  7. Bostick, 2007, UHRF1 plays a role in maintaining DNA methylation in mammalian cells, Science, 317, 1760, 10.1126/science.1147939 · DOI · Paper page
  8. Okano, 1999, DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development, Cell, 99, 247, 10.1016/S0092-8674(00)81656-6 · DOI · Paper page
  9. Hata, 2002, Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice, Development, 129, 1983, 10.1242/dev.129.8.1983 · DOI · Paper page
  10. Bourc’his, 2001, Dnmt3L and the establishment of maternal genomic imprints, Science, 294, 2536, 10.1126/science.1065848 · DOI · Paper page
  11. Goll, 2006, Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2, Science, 311, 395, 10.1126/science.1120976 · DOI · Paper page
  12. Xhemalce, 2013, From histones to RNA: role of methylation in cancer, Brief. Funct. Genomics, 12, 244, 10.1093/bfgp/els064 · DOI
  13. Tahiliani, 2009, Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1, Science, 324, 930, 10.1126/science.1170116 · DOI · Paper page
  14. Iyer, 2009, Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids, Cell Cycle, 8, 1698, 10.4161/cc.8.11.8580 · DOI · Paper page
  15. He, 2011, Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA, Science, 333, 1303, 10.1126/science.1210944 · DOI · Paper page
  16. Maiti, 2011, Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites, J. Biol. Chem., 286, 35334, 10.1074/jbc.C111.284620 · DOI · Paper page
  17. Li, 2015, Gadd45a promotes DNA demethylation through TDG, Nucleic Acids Res., 43, 3986, 10.1093/nar/gkv283 · DOI
  18. Rai, 2008, DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45, Cell, 135, 1201, 10.1016/j.cell.2008.11.042 · DOI · Paper page
  19. Wu, 2010, Active DNA demethylation: many roads lead to Rome, Nat. Rev. Mol. Cell Biol., 11, 607, 10.1038/nrm2950 · DOI · Paper page
  20. Kagiwada, 2013, Replication-coupled passive DNA demethylation for the erasure of genome imprints in mice, EMBO J., 32, 340, 10.1038/emboj.2012.331 · DOI · Paper page
  21. Hudson, 2018, Zinc finger readers of methylated DNA, Molecules, 23, 10.3390/molecules23102555 · DOI
  22. Vilas, 2018, Caught with one’s zinc fingers in the genome integrity cookie jar, Trends Genet., 34, 313, 10.1016/j.tig.2017.12.011 · DOI
  23. Hong, 2017, Methyl-dependent and spatial-specific DNA recognition by the orthologous transcription factors human AP-1 and Epstein-Barr virus Zta, Nucleic Acids Res., 45, 2503, 10.1093/nar/gkx057 · DOI
  24. Ginder, 2018, Readers of DNA methylation, the MBD family as potential therapeutic targets, Pharmacol. Ther., 184, 98, 10.1016/j.pharmthera.2017.11.002 · DOI
  25. Mahmood, 2019, DNA methylation readers and cancer: mechanistic and therapeutic applications, Front. Oncol., 9, 489, 10.3389/fonc.2019.00489 · DOI
  26. Stirzaker, 2017, Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer, Oncogene, 36, 1328, 10.1038/onc.2016.297 · DOI
  27. Hendrich, 1998, Identification and characterization of a family of mammalian methyl-CpG binding proteins, Mol. Cell. Biol., 18, 6538, 10.1128/MCB.18.11.6538 · DOI · Paper page
  28. Leighton, 2019, The Methyl-CpG-binding domain 2 and 3 proteins and formation of the nucleosome remodeling and deacetylase complex, J. Mol. Biol., 432, 1624, 10.1016/j.jmb.2019.10.007 · DOI
  29. Hendrich, 1999, The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites, Nature, 401, 301, 10.1038/45843 · DOI · Paper page
  30. Kimura, 2003, Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1, J. Biol. Chem., 278, 4806, 10.1074/jbc.M209923200 · DOI · Paper page
  31. Sharif, 2007, The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA, Nature, 450, 908, 10.1038/nature06397 · DOI · Paper page
  32. Zhou, 2014, Structural basis for hydroxymethylcytosine recognition by the SRA domain of UHRF2, Mol. Cell, 54, 879, 10.1016/j.molcel.2014.04.003 · DOI
  33. Filion, 2006, A family of human zinc finger proteins that bind methylated DNA and repress transcription, Mol. Cell. Biol., 26, 169, 10.1128/MCB.26.1.169-181.2006 · DOI · Paper page
  34. Hodges, 2019, Cys2His2 zinc finger methyl-CpG binding proteins: getting a handle on methylated DNA, J. Mol. Biol., 432, 1640, 10.1016/j.jmb.2019.09.012 · DOI
  35. Lang, 2017, CTCF prevents genomic instability by promoting homologous recombination-directed DNA double-strand break repair, Proc. Natl. Acad. Sci. U.S.A., 114, 10912, 10.1073/pnas.1704076114 · DOI · Paper page
  36. Hilmi, 2017, CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair, Sci. Adv., 3, e1601898, 10.1126/sciadv.1601898 · DOI
  37. Woodcock, 2019, Human MettL3-MettL14 complex is a sequence-specific DNA adenine methyltransferase active on single-strand and unpaired DNA in vitro, Cell Discov., 5, 63, 10.1038/s41421-019-0136-4 · DOI
  38. Hao, 2020, N(6)-Deoxyadenosine methylation in mammalian mitochondrial DNA, Mol. Cell, 78, 382, 10.1016/j.molcel.2020.02.018 · DOI · Paper page
  39. Xiong, 2019, N(6)-Hydroxymethyladenine: a hydroxylation derivative of N6-methyladenine in genomic DNA of mammals, Nucleic Acids Res., 47, 1268, 10.1093/nar/gky1218 · DOI
  40. Greenblatt, 1994, Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis, Cancer Res., 54, 4855
  41. Sassa, 2016, Mutagenic consequences of cytosine alterations site-specifically embedded in the human genome, Genes Environ., 38, 17, 10.1186/s41021-016-0045-9 · DOI
  42. Tommasi, 1997, Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases, Cancer Res., 57, 4727
  43. Deniz, 2019, Regulation of transposable elements by DNA modifications, Nat. Rev. Genet., 20, 417, 10.1038/s41576-019-0117-3 · DOI
  44. Rodic, 2014, Long interspersed element-1 protein expression is a hallmark of many human cancers, Am. J. Pathol., 184, 1280, 10.1016/j.ajpath.2014.01.007 · DOI · Paper page
  45. Chuang, 1997, Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1, Science, 277, 1996, 10.1126/science.277.5334.1996 · DOI · Paper page
  46. Pradhan, 2002, The retinoblastoma gene product interacts with maintenance human DNA (cytosine-5) methyltransferase and modulates its activity, EMBO J., 21, 779, 10.1093/emboj/21.4.779 · DOI
  47. Xia, 2019, Bacteria-to-human protein networks reveal origins of endogenous DNA damage, Cell, 176, 127.e24, 10.1016/j.cell.2018.12.008 · DOI
  48. Ren, 2020, Direct readout of heterochromatic H3K9me3 regulates DNMT1-mediated maintenance DNA methylation, Proc. Natl. Acad. Sci. U.S.A., 117, 18439, 10.1073/pnas.2009316117 · DOI · Paper page
  49. Jones, 1997, Altered DNA methylation and genome instability: a new pathway to cancer?, Proc. Natl. Acad. Sci. U.S.A., 94, 2103, 10.1073/pnas.94.6.2103 · DOI · Paper page
  50. Chen, 2007, Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells, Nat. Genet., 39, 391, 10.1038/ng1982 · DOI · Paper page
  51. Okano, 2002, Genetic analyses of DNA methyltransferase genes in mouse model system, J. Nutr., 132, 2462S, 10.1093/jn/132.8.2462S · DOI
  52. Ha, 2011, Rapid and transient recruitment of DNMT1 to DNA double-strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery, Hum. Mol. Genet., 20, 126, 10.1093/hmg/ddq451 · DOI · Paper page
  53. Lee, 2010, DNA methyltransferase 1-associated protein (DMAP1) is a co-repressor that stimulates DNA methylation globally and locally at sites of double strand break repair, J. Biol. Chem., 285, 37630, 10.1074/jbc.M110.148536 · DOI · Paper page
  54. Georgia, 2013, DNMT1 represses p53 to maintain progenitor cell survival during pancreatic organogenesis, Genes Dev., 27, 372, 10.1101/gad.207001.112 · DOI
  55. Loughery, 2011, DNMT1 deficiency triggers mismatch repair defects in human cells through depletion of repair protein levels in a process involving the DNA damage response, Hum. Mol. Genet., 20, 3241, 10.1093/hmg/ddr236 · DOI · Paper page
  56. Xia, 2017, CHD4 has oncogenic functions in initiating and maintaining epigenetic suppression of multiple tumor suppressor genes, Cancer Cell, 31, 653.e7, 10.1016/j.ccell.2017.04.005 · DOI · Paper page
  57. Cuozzo, 2007, DNA damage, homology-directed repair, and DNA methylation, PLoS Genet., 3, e110, 10.1371/journal.pgen.0030110 · DOI · Paper page
  58. Kafer, 2016, 5-Hydroxymethylcytosine marks sites of DNA damage and promotes genome stability, Cell Rep., 14, 1283, 10.1016/j.celrep.2016.01.035 · DOI · Paper page
  59. Jiang, 2017, TET3-mediated DNA oxidation promotes ATR-dependent DNA damage response, EMBO Rep., 18, 781, 10.15252/embr.201643179 · DOI
  60. Jiang, 2015, Alteration in 5-hydroxymethylcytosine-mediated epigenetic regulation leads to Purkinje cell vulnerability in ATM deficiency, Brain, 138, 3520, 10.1093/brain/awv284 · DOI · Paper page
  61. Lahtz, 2011, Epigenetic changes of DNA repair genes in cancer, J. Mol. Cell Biol., 3, 51, 10.1093/jmcb/mjq053 · DOI · Paper page
  62. Kang, 2001, Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma, Lab. Invest., 81, 573, 10.1038/labinvest.3780266 · DOI
  63. Chmelarova, 2013, Methylation in the p53 promoter in epithelial ovarian cancer, Clin. Transl. Oncol., 15, 160, 10.1007/s12094-012-0894-z · doi:10.1007/s12094-012-0894-z
  64. Jin, 2013, DNA methyltransferases, DNA damage repair, and cancer, Adv. Exp. Med. Biol., 754, 3, 10.1007/978-1-4419-9967-2_1 · DOI · Paper page
  65. Yan, 2011, Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia, Nat. Genet., 43, 309, 10.1038/ng.788 · DOI · Paper page
  66. Roller, 2013, Landmark analysis of DNMT3A mutations in hematological malignancies, Leukemia, 27, 1573, 10.1038/leu.2013.65 · DOI
  67. Shah, 2011, DNMT3A mutations in acute myeloid leukemia, Nat. Genet., 43, 289, 10.1038/ng0411-289 · DOI
  68. Park, 2020, Characteristics of DNMT3A mutations in acute myeloid leukemia, Blood Res., 55, 17, 10.5045/br.2020.55.1.17 · DOI
  69. Ferreira, 2016, DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia, Oncogene, 35, 3079, 10.1038/onc.2015.359 · DOI
  70. Kohlmann, 2005, New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes, Leukemia, 19, 953, 10.1038/sj.leu.2403746 · DOI
  71. Langemeijer, 2009, Acquired mutations in TET2 are common in myelodysplastic syndromes, Nat. Genet., 41, 838, 10.1038/ng.391 · DOI · Paper page
  72. Ko, 2010, Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2, Nature, 468, 839, 10.1038/nature09586 · DOI · Paper page
  73. Cimmino, 2015, TET1 is a tumor suppressor of hematopoietic malignancy, Nat. Immunol., 16, 653, 10.1038/ni.3148 · DOI · Paper page
  74. Huang, 2013, TET1 plays an essential oncogenic role in MLL-rearranged leukemia, Proc. Natl. Acad. Sci. U.S.A., 110, 11994, 10.1073/pnas.1310656110 · DOI · Paper page
  75. Subramaniam, 2014, DNA methyltransferases: a novel target for prevention and therapy, Front. Oncol., 4, 80, 10.3389/fonc.2014.00080 · DOI · Paper page
  76. Ganesan, 2019, The timeline of epigenetic drug discovery: from reality to dreams, Clin. Epigenet., 11, 174, 10.1186/s13148-019-0776-0 · DOI · Paper page
  77. Christman, 2002, 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy, Oncogene, 21, 5483, 10.1038/sj.onc.1205699 · DOI · Paper page
  78. Santi, 1984, Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine, Proc. Natl. Acad. Sci. U.S.A., 81, 6993, 10.1073/pnas.81.22.6993 · DOI · Paper page
  79. Palii, 2008, DNA methylation inhibitor 5-Aza-2′-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B, Mol. Cell. Biol., 28, 752, 10.1128/MCB.01799-07 · DOI · Paper page
  80. Orta, 2013, 5-Aza-2′-deoxycytidine causes replication lesions that require Fanconi anemia-dependent homologous recombination for repair, Nucleic Acids Res., 41, 5827, 10.1093/nar/gkt270 · DOI
  81. Zambrano, 2005, A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes, BMC Cancer, 5, 44, 10.1186/1471-2407-5-44 · DOI
  82. Cheng, 2003, Inhibition of DNA methylation and reactivation of silenced genes by zebularine, J. Natl. Cancer Inst., 95, 399, 10.1093/jnci/95.5.399 · DOI · Paper page
  83. Cheng, 2004, Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells, Mol. Cell. Biol., 24, 1270, 10.1128/MCB.24.3.1270-1278.2004 · DOI · Paper page
  84. Johnson, 2006, A pharmacokinetic/pharmacodynamic approach to evaluating the safety of zebularine in non-human primates, Cancer Res., 66, 309
  85. Zacharioudakis, 2017, Chromatin regulates genome targeting with cisplatin, Angew. Chem. Int. Ed. Engl., 56, 6483, 10.1002/anie.201701144 · DOI
  86. Pohlmann, 2002, Phase II trial of cisplatin plus decitabine, a new DNA hypomethylating agent, in patients with advanced squamous cell carcinoma of the cervix, Am. J. Clin. Oncol., 25, 496, 10.1097/00000421-200210000-00015 · DOI
  87. Viet, 2014, Decitabine rescues cisplatin resistance in head and neck squamous cell carcinoma, PLoS ONE, 9, e112880, 10.1371/journal.pone.0112880 · DOI
  88. Khandelwal, 2018, Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A, Mol. Cell. Biochem., 446, 105, 10.1007/s11010-018-3278-z · DOI
  89. Benson, 2015, Carboplatin with decitabine therapy, in recurrent platinum resistant ovarian cancer, alters circulating miRNAs concentrations: a pilot study, PLoS ONE, 10, e0141279, 10.1371/journal.pone.0141279 · DOI
  90. Muvarak, 2016, Enhancing the cytotoxic effects of PARP inhibitors with DNA demethylating agents - a potential therapy for cancer, Cancer Cell, 30, 637, 10.1016/j.ccell.2016.09.002 · DOI · Paper page
  91. Caron, 2019, Poly(ADP-ribose) polymerase-1 antagonizes DNA resection at double-strand breaks, Nat. Commun., 10, 2954, 10.1038/s41467-019-10741-9 · DOI · Paper page
  92. Luijsterburg, 2016, PARP1 links CHD2-mediated chromatin expansion and H3.3 deposition to DNA repair by non-homologous end-joining, Mol. Cell, 61, 547, 10.1016/j.molcel.2016.01.019 · DOI · Paper page
  93. Giri, 2019, DNMT inhibitors increase methylation in the cancer genome, Front. Pharmacol., 10, 10.3389/fphar.2019.00385 · DOI
  94. Ding, 2016, Mismatch repair proteins recruit DNA methyltransferase 1 to sites of oxidative DNA damage, J. Mol. Cell Biol., 8, 244, 10.1093/jmcb/mjv050 · DOI · Paper page
  95. Gong, 2017, Histone demethylase KDM5A regulates the ZMYND8-NuRD chromatin remodeler to promote DNA repair, J. Cell Biol., 216, 1959, 10.1083/jcb.201611135 · DOI · Paper page
  96. Bernstein, 2015, Epigenetic reduction of DNA repair in progression to gastrointestinal cancer, World. J. Gastrointest. Oncol., 7, 30, 10.4251/wjgo.v7.i5.30 · DOI
  97. Tessitore, 2014, MicroRNAs in the DNA damage/repair network and cancer, Int. J. Genomics, 2014, 820248, 10.1155/2014/820248 · DOI
  98. Juhasz, 2018, ATRX promotes DNA repair synthesis and sister chromatid exchange during homologous recombination, Mol. Cell, 71, 11.e7, 10.1016/j.molcel.2018.05.014 · DOI
  99. Hsieh, 2017, The Devil is in the details for DNA mismatch repair, Proc. Natl. Acad. Sci. U.S.A., 114, 3552, 10.1073/pnas.1702747114 · DOI
  100. Arab, 2019, GADD45A binds R-loops and recruits TET1 to CpG island promoters, Nat. Genet., 51, 217, 10.1038/s41588-018-0306-6 · DOI · Paper page
  101. Hansel-Hertsch, 2017, DNA G-quadruplexes in the human genome: detection, functions and therapeutic potential, Nat. Rev. Mol. Cell Biol., 18, 279, 10.1038/nrm.2017.3 · DOI · Paper page
  102. Mao, 2018, DNA G-quadruplex structures mold the DNA methylome, Nat. Struct. Mol. Biol., 25, 951, 10.1038/s41594-018-0131-8 · DOI · Paper page
  103. Joyce, 2018, DNA methylation of telomere-related genes and cancer risk, Cancer Prev. Res., 11, 511, 10.1158/1940-6207.CAPR-17-0413 · DOI

Cited by

See all 65

Metadata

Authors
Sriraman, A., Debnath, T. K., Xhemalce, B., & Miller, K. M.
Affiliations
Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, U.S.A.
Venue
Essays in Biochemistry
Published
2020-08-18
Volume
64
Issue
5
Pages
687-703
ISSN
  • 0071-1365
  • 1744-1358
Cited by
65
References
27
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Making it or breaking it: DNA methylation and genome integrity. https://app.cochat.ai/papers/10.1042/ebc20200009
The paper
Sriraman, A., Debnath, T. K., Xhemalce, B., & Miller, K. M. (2020). Making it or breaking it: DNA methylation and genome integrity. Essays in Biochemistry. https://doi.org/10.1042/ebc20200009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.